Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Bristol Myers Squibb at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Bristol Myers Squibb brings 5 presentations to Discovery on Target 2026 in Boston. Its program centres on covalent drug design and direct-to-biology chemistry. It also covers a brain-penetrant covalent BTK inhibitor and an EP4 agonist for inflammatory bowel disease.

OrganizationDiscovery on Target 2026 Attendance
Large pharma
Global biopharmaceutical company with medicines in oncology, immunology, cardiovascular disease and neuroscience.
Talk
Tue Sep 29
8:35am–9:05am
Advancing KRAS G12C Active-State Inhibition through Next-Generation Covalent Warhead Design
Lead Generation Strategies
Panel
Tue Sep 29
5:00pm–6:00pm
Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach
Plenary · with Drug Hunter, Amgen, Novartis +3 more
Novel drug modalitiesInnovative discovery technologies
Panel
Wed Sep 30
7:30am–8:15am
Covalent Drug Design Strategies
Lead Generation Strategies · with GSK
Talk
Thu Oct 1
12:20pm–12:50pm
Talk
Thu Oct 1
3:35pm–4:05pm

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bristol Myers Squibb

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction